NCAM1 and Miyoshi myopathy: Sahara N et al. [16] reported that MM with CD56 negative had a poor prognosis with higher chance of extramedullary disease, Bence Jones protein, renal insufficiency, thrombocytopenia, and plasma cell morphology.